Hemastatx jobs and careers
Switzerland
As of October 23, 2026, Hemastatx has no open roles listed.
About Hemastatx
Hemastatx is committed to bringing scientific innovation to patients with severe and underserved bleeding disorders, aiming to become a leader in hematology. Founded in 2025 as a spin-off from KU Leuven, Hemastatx builds on over a decade of pioneering research in hemostasis at the Laboratory for Thrombosis Research, led by Prof. dr. Karen Vanhoorelbeke. Our first lead program, HMX-001, is a proprietary monoclonal antibody designed to present bleeding in patients with von Willebrand factor (VWF)-related disorders by targeting the underlying biological mechanism. The program is supported by a robust preclinical data package and broad patent protection. With headquarters in Switzerland and an R&D hub in Belgium, Hemastatx is strategically positioned within two of Europe’s leading biotech ecosystems.
- Employees
- 1 to 10
- Headquarters
- Switzerland
Jobs at Hemastatx
No open positions right now. Explore more companies on TheJobsMap.
Hemastatx jobs: common questions
- Is Hemastatx hiring right now?
- Hemastatx has no open roles listed as of October 23, 2026. Roles appear here as soon as they are posted on Hemastatx's careers site.
- Where is Hemastatx headquartered?
- Hemastatx is headquartered in Switzerland.
- How do I apply for a job at Hemastatx?
- Pick a role on Hemastatx's TheJobsMap page and select Apply. Every listing links to the original posting on Hemastatx's own careers site, so you apply directly with the employer.